 H.C. Wainwright analystRam Selvarajureiterated aBuyrating on Fennec Pharmaceuticals FENCResearch Report today and set a price target of17.00. The companys shares closed last Tuesday at 6.95.According toTipRanks.com, Selvaraju is a 